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Abstract 
Background: hGlyrichin is a novel human antimicrobial peptide rich in glycine. The previous study of known human 
antimicrobial peptides indicated that in an eligible range, the greater corresponding antibacterial activity was con-
sisted with the shorter peptide sequence.
Findings: Two peptides named pCM19 and pCM12 were synthesized and the antibacterial activity assay results 
showed that these peptides exhibited strong antibacterial activity that was inversely proportional to the length of the 
peptide. Despite the effective inhibition of bacterial growth, the synthetic peptides showed no hemolytic effect on 
human red blood cells.
Conclusions: Taken together, these two peptides derived from hGlyrichin both have strong antibacterial activity and 
are not toxic to human somatic cells.
Keywords: Antimicrobial peptides, hGlyrichin, Hemolytic effect
© 2016 The Author(s). This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made.
Background
Mature antimicrobial peptides are usually processed 
from their precursors (Vassilevski et al. 2008; Brown and 
Hancock 2006). The post-translational modifications of 
peptides include proteolysis, glycosylation, C-terminal 
amidation, amino acid isomerization, and halogenation. 
After the mature peptide is formed by a cleavage process, 
it is antimicrobially active.
By comparing the sequences of the defensin family 
from plants, insects, birds, mammals, and other species, 
Yount and Yeaman identified a highly conserved three-
dimensional structure containing disulfide bonds, known 
as the γ core motif (Yeaman and Yount 2003). This spe-
cial bi-directional amino acid sequence motif contains 
two anti-parallel β-sheet structures and a short coil insert 
sequence, and exists in all species, suggesting that the 
defensins from different species may be derived from a 
common precursor (Ganz 2003; Selsted and Ouellette 
2005). The results suggest that the γ core motif may be 
the functional domain of the defensin family.
The cathelicidin family is known to contain 30 members. 
According to its structural characteristics, the cathelicidin 
family can be classified into four subfamilies (Lehrer and 
Ganz 2002; Bals and Wilson 2003). The cathelin-like struc-
ture in the C segment is a common feature in all members 
of this family. At present, the most active sequence in the 
cathelicidin family is LL-37, which is the shortest sequence 
and is expressed by human leukocytes.
Furthermore, analysis of the antimicrobial activities of 
peptides from bactenecin showed that their antibacterial 
activity was increased and their antibacterial spectrum was 
broadened when the peptide length was shortened from 12 
amino acids to eight amino acids (Hilpert et al. 2005).
hGlyrichin is a new peptide isolated from a human fetal 
liver cDNA library. The amino acid sequence of hGlyrichin 
is rich in glycine (Sha et al. 2012). Chung et al. named this 
same gene Romo1 (reactive oxygen species modulator 1) in 
2006 and showed that it encodes a protein that is identical to 
hGlyrichin (Chung et al. 2006). Bioinformatics analysis indi-
cated it has 79 amino acid residues, >21 % of which are gly-
cine, and the pI value is 9.58. Secondary structure analysis 
shows that hGlyrichin is an amphiphilic molecule contain-
ing mainly β-sheets with alternating hydrophilic and hydro-
phobic regions. This characteristic is highly consistent with 
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the structural characteristics of cationic antimicrobial pep-
tides. Functional analysis of the synthetic peptides revealed 
that hGlyrichin is an important member of a potentially 
novel human cationic antimicrobial peptide family, which 
may act on the bacterial membrane (Sha et al. 2012).
In order to verify whether or not hGlyrichin was in 
accord with the regular pattern mentioned above: in an 
eligible range, the shorter the peptide sequence is, the 
greater the corresponding antibacterial activity is (Kin-
drachuk  2010; Hwang and Vogel  1998; Sørensen  et al. 
2001), we compared the antibacterial activity and hemo-
lytic side effects of two peptides derived from hGlyrichin.
Methods
Bacteria strains and cells
Escherichia coli (E. coli) BL21 and ampicillin-resistant 
(AmpR) E. coli BL21 (E. coli BL21 transformed with the 
pET-22b+ plasmid which carried the ampicillin-resistant 
gene) were maintained in our laboratory. Staphylococcus 
aureus (S. aureus, ATCC 25923), ampicillin-resistant S. 
aureus (S. aureus AmpR, ATCC BAA-44), and Salmonella 
Typhi (S. Typhi, ATCC 19430) were maintained at the 
Institute of Microbiology of Military Academy of Medical 
Sciences. The antimicrobial activity assays were completed 
in a specialized laboratory. Red blood cells were collected 
from healthy adults at the 307 hospital laboratory. All par-
ticipants gave informed consent to participate in the study.
Peptide synthesis
All peptides were synthesized by GL Biochem (Shanghai, 
China), and their sequences are as follows: pCM19 (con-
tains 19 amino acids from positions 42 to 60, which had 
been authenticated as crucial fragment for the antibacte-
rial activity of hGlyrichin in our previous study) (Sha et al. 
2012), CLRIGMRGRELMGGIGKTM; pCM12 (12 amino 
acids of pCM19 from which 7 amino acids at the car-
boxyl terminal were removed), CLRIGMRGRELM; Flex-
ible fragment (FF), a GIG array that is more like a flexible 
unit and represents the portion that is different between 
pCM19 and pCM12, GGIGKTM; Positive control (PC, 
a peptide segment based on the P2 polypeptide of the 
human neutrophil bactericidal permeability increasing 
protein, BPI) (Barker et  al. 2000), SKISGKWKAQKR-
FLKMSGNFGC; Random control (RC, a random array of 
pCM12), GICRLMMRRGLE; pCM11 (pCM12 with the 
last amino acid residue removed), CLRIGMRGREL. All of 
the peptides were diluted to 20 mg/ml with sterile deion-
ized water as stock solutions and stored at −20 °C.
Experimental methods
Bacteria colony counting method
A total of 5  µl of the bacteria solution at OD600  =  0.3 
containing E. coli BL21, E. coli BL21 AmpR, S. aureus, S. 
aureus AmpR, or S. Typhi, were diluted to 20 µl with LB 
medium. A total of 10 µl of the peptide solution contain-
ing 100  µg of the peptides (pCM19, pCM12, pCM11, 
flexible peptide, randomized control peptide, or the 
positive control peptide), 10 µl of Amp solution (contain-
ing Amp 100 µg), or 10 µl of double-distilled water was 
added, mixed well, and incubated at 37 °C for 2 h. Twenty 
microliters of the culture was diluted in LB (final volume 
1 ml) and was evenly coated on an LB plate, inverted and 
incubated at 37 °C for 12–18 h and then the bacterial col-
onies were counted.
Bacterial growth curve method
Eight microliters of bacterial solution at OD600  =  2.5 
containing E. coli BL21, E. coli BL21 AmpR, S. aureus, 
S. aureus AmpR, or S. Typhi were mixed with 12  µl of 
the peptide solution containing 120  µg of the peptide 
(pCM19, pCM12, pCM11, flexible peptide, randomized 
control peptide, or the positive control peptide), or 12 µl 
Amp solution (containing 120 µg Amp), or 12 µl of dou-
ble-distilled water. The mixtures were mixed well, and 
incubated at 37  °C for 1  h. LB was added to bring the 
volume up to 4  ml, and the incubation was continued 
at 37  °C and 175 rpm for 10 h. Fifty microliters of each 
samples were taken every 2 h, and the absorbance of each 
sample at 600 nm was determined by spectrophotometry. 
The bacterial growth curve was calculated.
In vitro hemolysis assay
Blood samples from healthy donors were treated with hep-
arin to minimize clotting. The blood cell was washed three 
times with normal saline, and 8 µl samples were diluted to 
100 µl in normal saline. The diluted blood cell (100 µl) was 
incubated with 100 µl of pCM19 (3000 µg/ml) for 1 h at 
37 °C; then the same volume diluted blood cell was incu-
bated with 100  µl of pCM12 (100, 200, 500, 1000, 2000, 
3000  µg/ml) for 1  h at 37  °C. Centrifugation was carried 
out at 1000 rpm for 5 min at 4 °C. Each treatment was per-
formed in triplicate. The absorbance of each sample was 
measured at 570 nm using a microplate reader. The control 
group contained samples treated with 100 µl normal saline 
(negative control), 0.1 % Triton X-100 (positive control), or 
ampicillin (3000 µg/ml, traditional antibiotic) respectively, 
and the controls were treated in triplicate.
Results
The antibacterial activity identification and comparison 
of the peptide pCM19 and pCM12
Analysis of antibacterial activity based on bacteria colony 
counting
As shown in Fig.  1, the pCM19 and pCM12 peptides 
effectively inhibited the growth of both Gram-negative 
bacterium (E. coli BL21 and S. Typhi) and Gram-positive 
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bacterium (S. aureus). Most importantly, both of these 
peptides showed good inhibition and killing of the ampi-
cillin-resistant bacteria E. coli BL21 AmpR and S. aureus 
AmpR. A comparison of the overall antimicrobial activities 
showed that pCM12 had stronger antimicrobial activity 
than pCM19. Additionally, the antimicrobial activity of 
pCM12 was similar or slightly better than the positive con-
trol peptide, while the flexible peptide from the C-terminal 
GIG region of pCM19, almost completely lost the antibac-
terial activity. In addition, when the amino acid sequence 
Fig. 1 Analysis of the antibacterial activity of different peptides by bacteria colony counting. Antibacterial effect of different peptide segments was 
compared on E. coli BL21 (a), E. coli BL21 AmpR (b), S. aureus (c), S. aureus AmpR (d) and S. Typhi (e). Data are expressed as the mean ± SD (n = 5)
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of pCM12 was altered by random rearrangement, the RC 
peptide almost completely lost its bactericidal activity, 
which suggested that a particular amino acid sequence 
(which called primary structure of the peptide) was desi-
cive for its antibacterial activity. However, when the last 
amino acid of pCM12 was removed, the pCM11 peptide 
also lost its antibacterial activity, indicated that the Met 
amino acid residue was significant for maintaining the 
nature activity of the peptide.
Analysis of the antibacterial activity based on the bacterial 
growth curve
As shown in Fig. 2, during the first 10 h incubation, the 
antibacterial effects of pCM19 and pCM12 remained sta-
ble. The data obtained from the growth inhibition and 
killing analysis on E. coli BL21, S. aureus, and S. Typhi 
as well as the ampicillin-resistant bacteria E. coli BL21 
AmpR and S. aureus AmpR were essentially consistent 
with the results of colony counting. A comparison of the 
Fig. 2 Analysis of the antibacterial activity of different peptides by bacterial growth curve. Antibacterial effect of different peptide segments was 
compared on E. coli BL21 (a), E. coli BL21 AmpR (b), S. aureus (c), S. aureus AmpR (d) and S. Typhi (e). Data are expressed as the mean ± SD (n = 5)
Page 5 of 6Sha and Zhang  SpringerPlus  (2016) 5:1382 
overall antimicrobial activities showed that pCM12 had 
more potent antimicrobial activity than pCM19. Com-
pared with the positive control peptide, the antimicrobial 
activity of pCM12 was similar or slightly better, while 
neither the flexible peptide from the C-terminal GIG 
region of pCM19, nor pCM11 and the random control 
peptide showed no obvious antimicrobial activities.
Compared with pCM19, the peptide sequence of pCM12 
is shorter, which will significantly reduce the difficulty and 
the cost associated with its synthesis, and make this pep-
tide more amenable to practical applications.
Results of the in vitro hemolysis assay of the peptide 
pCM19 and pCM12
Following the incubation of human blood cells with 
pCM19 or pCM12, the OD570 value was measured. 
pCM12 and pCM19, even at a much higher concentra-
tion than the effective antibacterial dose, caused no dam-
age to the red cell membranes and were comparable to 
the negative control groups that were treated with water 
or ampicillin (Table 1). Thus, these two peptides derived 
from hGlyrichin exhibited good selectivity between the 
bacterial membranes and normal human cell membranes.
Discussion
Antimicrobial peptides are highly conserved molecules 
despite of the diversities among their sequences and 
structures. Almost more than 2000 antimicrobial pep-
tides have been identified, and they can be classified into 
a few conformational models (Powers and Hancock 2003; 
Hilpert et al. 2006). Newly identified antimicrobial pep-
tides, especially human origined cationic antimicrobial 
peptides, have become an important platform for the dis-
covery of novel antimicrobial agents for emerging drug-
resistant bacteria.
hGlyrichin is a human cationic antimicrobial peptide 
encoded by an evolutionarily highly conserved gene. 
In our previous study, we confirmed the 19 amino acid 
peptide (pCM19) at positions 42–60 of hGlyrichin is 
crucial for its antibacterial activity. Thus, we wanted 
to investigate whether it consist with the same regu-
lar pattern summarized before: in an eligible range, the 
shorter the peptide sequence length, the greater the cor-
responding antibacterial activity. So we synthesized the 
peptide pCM12, and compared its antibacterial activ-
ity with pCM19. pCM19 and pCM12 were derived from 
hGlyrichin and showed significant inhibition and killing 
activities against the laboratory-engineered bacteria, 
Gram-positive bacteria, Gram-negative bacteria, and 
ampicillin-resistant bacteria. The results indicated that 
pCM12 showed a slightly better antimicrobial activity 
than that of pCM19 for most target bacteria. The inactiv-
ity of the random control peptide and pCM11 confirmed 
the importance of the correct amino acid sequence and 
the last amino acid for the observed antibacterial activ-
ity. The in vitro hemolysis assay showed that the peptides 
from hGlyrichin had a high degree of selectivity for bac-
terial membrane. Even at higher concentrations, they did 
not damage the normal red blood cells.
The additional results indicated that after the N-ter-
minal cysteine of pCM19 is removed, its antibacterial 
activity has almost completely lost, which suggests that 
cysteine also played a crucial role in maintaining the 
bactericidal activity of this peptide. It was known that 
the number of net positive charges of the antimicro-
bial peptide was an important structure element which 
affected the interaction between cationic antimicrobial 
peptides and the negatively charged phospholipid mem-
branes. However, based on the known structure pCM19, 
the synthetic peptides with increased net positive charge 
number did not show distinct improvement of antibacte-
rial activity (unpublished data, Sha et al.). These results 
suggest that, in killing bacteria, the integrity of the bac-
tericidal domain plays more important role than the 
overall charge of the peptide. Due to the results above, 
the peptides of hGlyrichin have the potential to be devel-
oped into a new type of safe and effective antibacterial 
agent.
In fact, the structure of the antimicrobial peptide and 
its activity are governed by its degree of cationization 
(positive charge content), amphiphilic characteristics, 
hydrophobic characteristics, structural tendency, amino 
acid sequence composition, angular degree, and amphi-
philic balance, or cation/hydrophobic balance, that is 
the optimum ratio between the number of cations and 
the peptide’s hydrophobicity (Yeaman and Yount 2003; 
Barker et  al. 2000; Zasloff et  al. 1988; Takahashi et  al. 
2010; Bechinger 2011; Palermo and Kuroda 2010). To 
Table 1 In vitro hemolysis assay of  the peptides pCM19 
and pCM12
Solution Sample 1 Sample 2 Sample 3 Mean SD
Triton X-100 4.949 6.000 5.552 5.500 0.5274
pCM19 (100 µg/ml) 0.088 0.131 0.093 0.104 0.0235
pCM19 (3000 µg/ml) 0.131 0.127 0.142 0.133 0.0078
pCM12 (100 µg/ml) 0.105 0.123 0.104 0.111 0.0107
pCM12 (200 µg/ml) 0.114 0.116 0.122 0.117 0.0042
pCM12 (500 µg/ml) 0.120 0.134 0.136 0.130 0.0087
pCM12 (1000 µg/ml) 0.140 0.141 0.141 0.141 0.0006
pCM12 (2000 µg/ml) 0.140 0.141 0.140 0.140 0.0006
pCM12 (3000 µg/ml) 0.105 0.123 0.104 0.111 0.0107
Normal saline 0.187 0.162 0.176 0.175 0.0125
Amp (3000 µg/ml) 0.076 0.152 0.103 0.110 0.0535
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further clarify the relationships between these primary 
structure parameters and the antimicrobial activities of 
the peptides, high-throughput methods such as combi-
natorial chemistry (Hilpert et  al. 2006; Fjell et  al. 2012) 
should be helpful.
Conclusions
In this study, based on the in-depth antibacterial activity 
analysis of the peptides derived from hGlyrichin, we con-
cluded that, as compared with the 19 amino acid peptide 
pCM19, the shorter peptide pCM12 is more effective in 
killing bacteria, in particular, the bacteria with antibi-
otic resistance and high virulence. This conclusion is also 
consistent with what has been observed with defensins, 
cathlicidins, and bactenecins. Finally, the inactivity of 
pCM11 demonstrates the critical role of the last Met resi-
due of pCM12 in killing bacteria.
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